Accessibility settings

Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46571, first published .
Woman holds smartphone displaying "Hvem er Rosa" app with breast cancer awareness ribbon.

Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study

Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study

Elen Siglen   1, 2 , MSc ;   Hildegunn Høberg Vetti   1, 2 , MD, PhD ;   Mirjam Augestad   2 , MSc ;   Vidar M Steen   1, 3 , MD, PhD ;   Åshild Lunde   4 , PhD ;   Cathrine Bjorvatn   1, 2 , PhD

1 Western Norway Familial Cancer Center, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway

2 Faculty of Health Studies, VID Specialized University, Bergen, Norway

3 Department of Clinical Science, University of Bergen, Bergen, Norway

4 Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway

Corresponding Author:

  • Elen Siglen, MSc
  • Western Norway Familial Cancer Center
  • Department of Medical Genetics
  • Haukeland University Hospital
  • Jonas Lies veg 61
  • Bergen 5021
  • Norway
  • Phone: 47 99569845
  • Email: elen.siglen@helse-bergen.no